Brookdale Announces Fourth Quarter Common Stock Dividen... ( CHICAGO Dec. 14 /- Brookdale Seni...)

Brookdale Announces Fourth Quarter Common Stock Dividend of $0.50

Date:12/14/2007

CHICAGO, Dec. 14 /PRNewswire-FirstCall/ -- Brookdale Senior Living Inc. (NYSE: BKD) announced today that its Board of Directors has declared a quarterly cash dividend on its common stock of $0.50 per share for the quarter ending December 31, 2007. The $0.50 per share dividend is payable on January 14, 2008 to holders of record of Brookdale's common stock on December 31, 2007.

Brookdale Senior Living Inc. is a leading owner and operator of senior living facilities throughout the United States. The Company is committed to providing an exceptional living experience through properties that are designed, purpose-built and operated to provide the highest-quality service, care and living accommodations for residents. Currently the Company owns and operates independent living, assisted living, and dementia-care facilities and continuing care retirement centers, with 550 facilities in 35 states and the ability to serve over 52,000 residents.

For more information regarding Brookdale and to be added to our email distribution list, please visit http://www.brookdaleliving.com.

SOURCE Brookdale Senior Living Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Post Your Comments:

(Date:5/12/2008)...ynchronized Slides at 5pm Today, LAWRENCE, Mass.,... Inc.,(Nasdaq: NXTM ), a leading manufacturer of ...financial results for the first quarter ended Marc...08 were $31.0 million, compared to,$8.4 million in...e fourth,quarter of 2007. Revenues in the in-cente...

(Date:5/12/2008)...all/ - SXC Health Solutions, Corp.,(NASDAQ: SXCI ...ts,management services and healthcare IT solutions...Shareholders will be held on Monday, May 12, 2008 ...t the Marriott Downtown, 540,North Michigan Avenue...bcast live. To access the webcast go to:, http:/...

(Date:5/12/2008)...inia Commonwealth University School of Medicine ha...million from the National Institutes of Healths Na...nt to examine polycystic ovary syndrome, a disorde...5 million women. , Polycystic ovary syndrome, or...ular menstrual cycles, excess facial and body hair...

(Date:5/12/2008)...y safety and quality of technically ...ay 12 /PRNewswire/ -- C5 Medical Werks, a leading ...ce industry, has submitted a 510(k),pre-market not... (FDA) for,its new technical ceramic dental compon...zirconium material ideally suited to meet the high...

[0] NxStage Medical Reports First Quarter 2008 Results [0] SXC Health Solutions to host annual meeting of shareholders May 12, 2008 at 5:30 pm ET/4:30 pm CT [0] NIH grant to support Translational Research Center for PCOS [0] C5 Medical Werks Applies for Clearance, Certification and Licensing for the Global Marketing of ZirDent(TM) Ceramic CAD/CAM Dental Blocks

...k of Hepatitis-A among students of Jiangxi Univers...cern to health officials in the province.// This ... resulted in the hospitalization of 64 students, a... Xinhua News Agency reports that the students who ...

...dvances in technology, new high technology based t...re is being designed by researchers of Johns Hopki...ole medical procedure a lot more safe and effectiv...t that could enable surgeons, operating in the nar...

...s at the University of Pennsylvania School of Medi... translates blood flow into gene expression. The//...ryonic development a transcription factor called K...ls, is activated by rapid, pulsed blood flow, as r...

...a government Wednesday amended the rules governing... in a bid to regulate them.// The state cabinet d...f school managements, students and employees, an o...ool managements will now be required to provide ad...

Other Medicine News:Health News:Snake Like Robots Designed to Assist Surgeons 2 Health News:Snake Like Robots Designed to Assist Surgeons 3 Health News:How Blood Flow Dictates Gene Expression 2

Outbreak Of Hepatitis-A Among College Students Causes Concern In Nanchang Snake Like Robots Designed to Assist Surgeons How Blood Flow Dictates Gene Expression Haryana Adopts New Rules for Private Schools

(Date:5/8/2008).../- Globus Medical, Inc., the largest,...world and a recognized,leader in motion preservati...nrollment in its SECURE(R)-C Cervical Artificial D...to mimic the normal motion of the spine in,order t...ative to fusion in,the treatment of symptomatic ce...

(Date:5/8/2008)...ty data support potential of asenapine in the trea...r I disorder, WASHINGTON, May 8 /PRNewswire-First... today announced that an overview of asenapine cli...d at the 161st Annual Meeting of the,American Psyc...Data from,the studies, involving patients with bip...

(Date:5/8/2008)...vides "Blueprint" to Produce Therapeutic Proteins ...PRNewswire-USNewswire/ -- Using gene,therapy, plas...ns through,skin flaps placed on cancerous tumors o..., according to a study in the May issue of Plastic...al journal of the American,Society of Plastic Surg...

(Date:5/8/2008)...sentations to Focus on Use of Pro-Healing Stent wi...ual-Antiplatelet Therapy, HONG KONG, May 8 /PRNew...randomized pilot study and the real-world registry..., the world,s first pro-healing stent, will be,pre... Barcelona, Spain., The symposium, titled "Clinic...

Breaking Medicine Technology:Globus Medical Completes Enrollment Of SECURE(R)-C Cervical Artificial Disc Clinical Trial 2 Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting 2 Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting 3 Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting 4 Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting 5 Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting 6 Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting 7 Skin Flaps Deliver Cancer-fighting Therapy, ASPS Study Reveals 2 Skin Flaps Deliver Cancer-fighting Therapy, ASPS Study Reveals 3 Data from Randomized Pilot Study, Real-World Use of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) to be Presented in Symposium at EuroPCR 2008 2 Gentiva 28R 29 Health Services Schedules First Quarter Earnings Call and Web Cast for Thursday May 1 2008 16806 1 Gentiva 28R 29 Health Services Schedules First Quarter Earnings Call and Web Cast for Thursday May 1 2008 16806 2 Gentiva 28R 29 Health Services Schedules First Quarter Earnings Call and Web Cast for Thursday May 1 2008 16806 3 Featured Stocks on Todays Edition of WallSt nets 3 Minute Press Show 3A NPHC PECD PNRR 4595 1 Featured Stocks on Todays Edition of WallSt nets 3 Minute Press Show 3A NPHC PECD PNRR 4595 2 Featured Stocks on Todays Edition of WallSt nets 3 Minute Press Show 3A NPHC PECD PNRR 4595 3 Data Presented at AACR Annual Meeting Shows Bavituximab Equivalent Plus Docetaxel Reduces Tumor Growth By Up to 95 25 and Halts Metastasis in a Model 1785 1 Data Presented at AACR Annual Meeting Shows Bavituximab Equivalent Plus Docetaxel Reduces Tumor Growth By Up to 95 25 and Halts Metastasis in a Model 1785 2 Data Presented at AACR Annual Meeting Shows Bavituximab Equivalent Plus Docetaxel Reduces Tumor Growth By Up to 95 25 and Halts Metastasis in a Model 1785 3 Data Presented at AACR Annual Meeting Shows Bavituximab Equivalent Plus Docetaxel Reduces Tumor Growth By Up to 95 25 and Halts Metastasis in a Model 1785 4 Data Presented at AACR Annual Meeting Shows Bavituximab Equivalent Plus Docetaxel Reduces Tumor Growth By Up to 95 25 and Halts Metastasis in a Model 1785 5 Ingenuity Systems and Pfizer Announce Strategic Partnership for Pathway Analysis 4592 1 Ingenuity Systems and Pfizer Announce Strategic Partnership for Pathway Analysis 4592 2 Ingenuity Systems and Pfizer Announce Strategic Partnership for Pathway Analysis 4592 3

[0] Globus Medical Completes Enrollment Of SECURE(R)-C Cervical Artificial Disc Clinical Trial [0] Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting [1] Skin Flaps Deliver Cancer-fighting Therapy, ASPS Study Reveals [0] Data from Randomized Pilot Study, Real-World Use of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) to be Presented in Symposium at EuroPCR 2008

...ridopyrazine-urea derivative compound series,show ...luable for,cancer treatment, QUEBEC, April 16, 200... a global, pure play biopharmaceutical company foc...ented an abstract,outlining first in vitro data on...ity for PI3K inhibition, at the American,Associati...

...vide Cancer Patients With Improved Potential to,Ba...07 /PRNewswire/ -- Insert,Therapeutics, Inc., a ma...oration announced today its novel delivery system,...presentation at,the 2007 American Association for ...ar, this poster includes new research findings,on ...

Other Medicine Technology:AEterna Zentaris Discloses First In Vitro Data for its PI3K,Inhibitors at the AACR Annual Meeting in Los Angeles 2 AEterna Zentaris Discloses First In Vitro Data for its PI3K,Inhibitors at the AACR Annual Meeting in Los Angeles 3 Poster on Cyclosert Drug Delivery Presented at AACR Meeting 2 Poster on Cyclosert Drug Delivery Presented at AACR Meeting 3 Poster on Cyclosert Drug Delivery Presented at AACR Meeting 4

AEterna Zentaris Discloses First In Vitro Data for its PI3K,Inhibitors at the AACR Annual Meeting in Los Angeles Poster on Cyclosert Drug Delivery Presented at AACR Meeting

Alcon offers medical grade perfluoropropane (SF6) intraocular gases for ophthalmological use.

Highly concentrated daily cleaner with Microclens beads for superior cleaning action.

Bausch & Lomb concentrated cleaner is a sterile, concentrated homogeneous surfactant solution containing alkyl ether sulfate, ethoxylated alkyl phenol, tri-quaternary cocoa-based phospholipid and sil

Optimum C/D/S Solution is a sterile cleaning, disinfecting, and storage solution for use with fluorosilicone acrylate and silicone acrylate rigid gas permeable (RGP) and hard contact lenses.

Medicine Products:

Ispan SF6 Intraocular Gases Opti-Clean II Bausch & Lomb Concentrated Cleaner Optimum by Lobob Cleaning/Disinfecting/Storage Solution

Brookdale Announces Fourth Quarter Common Stock Dividen...( CHICAGO Dec. 14 /- Brookdale Seni...),Health